About Aster DM Healthcare Limited

Aster DM Healthcare Limited operates as a major healthcare service provider across India through its network of multi-specialty hospitals and clinics and laboratories and licensed pharmacies. The Company operated 19 hospitals with 5,159 beds and 262 labs and patient experience centers and 203 pharmacies through Alfaone Retail Pharmacies Private Limited under Aster brand license and 10 clinics across five states in FY 2024–25. The healthcare services span from primary to quaternary levels through its “We’ll Treat You Well” promise.

The company began as a single-doctor clinic in Dubai during 1987 before entering India through MIMS Kozhikode in 2001 and then built Aster Medcity (Kerala) and Aster CMI (Bengaluru) in 2014. The company launched Aster Labs in 2020 followed by the introduction of an asset-light O&M model in 2022 before conducting multiple business expansions during 2023. The Company separated its GCC and India operations in 2024 before announcing its merger with Quality Care India Limited (QCIL) during the 2024–25 fiscal year and introducing the Aster Health App during this time.

The Group finished its GCC business divestment on April 3 2024 and began operating as a single Indian-focused entity. The consolidated group information report from March 31 2025 shows 10 direct subsidiaries and additional step-down subsidiaries. The Company presents 20 subsidiaries and associates that include step-down subsidiaries in its Business Responsibility and Sustainability section for disclosure purposes.

Aster DM Healthcare Limited Milestone 

The company achieved two key milestones during 2018 when it listed on NSE and BSE and it continues to expand its capacity to reach 5,159 beds in FY25 while focusing its operations on the Indian market.

Aster DM Healthcare Limited’s Business Segments

The Hospitals and Clinics segment generates 94% of the company’s revenue during FY25 while Labs and Wholesale Pharmacy operations produce 6% of revenue.

Note: These percentages represent the Indian market segment only.

Aster DM Healthcare Limited Key Management

• Dr. Azad Moopen serves as the Chairman and Managing Director of the company
• Ms. Alisha Moopen holds the position of Deputy Managing Director at the company
• Mr. T. J. Wilson serves as a Director at the company
• Mr. Sunil Kumar M R serves as the Chief Financial Officer of the organization
• The Chief Operating Officer position at the company is held by Mr. Ramesh Kumar S
• Dr. Anup R Warrier serves as the Chief Medical Affairs and Quality Officer at the organization
• Mr. Hari Prasad V K serves as the Head of Internal Audit Risk and Compliance at the organization 
• Mr. Hemish Purushottam serves as the Company Secretary and Compliance Officer at the organization

Latest Updates on Aster DM Healthcare Limited

• The company finished its GCC business divestment on April 3, 2024 to concentrate on Indian operations. 
• The company announced its merger with QCIL to form a leading Indian hospital network after receiving CCI approval on April 15, 2025 while waiting for SEBI and Stock Exchange approvals and NCLT process initiation. 
• The Aster Health App launched its services across 10 hospitals in Kerala Karnataka Telangana and Maharashtra to provide digital registration and appointment scheduling and virtual consultations and in-hospital check-ins and payment processing and medical record access. The company expanded its bed capacity by 300 units through the addition of 100 beds at MIMS Kannur and Aster Medcity which brought the total installed capacity to 5,159 beds. 
• The company welcomed new marquee investors after Olympus Capital sold its 20% stake during FY25. 
• The company received three major awards during FY25 including Best Multispecialty Hospital – Group from ASSOCHAM and Best Hospital Chain from Financial Express and Best Healthcare Brand from The Economic Times.